Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
|
P
|
Pushpay Holdings Ltd
ASX:PPH
|
NZ |
|
Bhansali Engg Polymers Ltd
NSE:BEPL
|
IN |
|
D
|
DEE Development Engineers Ltd
NSE:DEEDEV
|
IN |
|
Zeus Resources Ltd
ASX:ZEU
|
AU |
|
E
|
e-Starco Co Ltd
KRX:015020
|
KR |
|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
KR |
|
M
|
Mitra Komunikasi Nusantara Tbk PT
IDX:MKNT
|
ID |
|
B
|
Borregaard ASA
SWB:BO4
|
NO |
|
T
|
Tegna Inc
XBER:GTT
|
US |
|
G
|
GMO Internet Group Inc
XMUN:IQ3
|
JP |
|
S
|
Super Energy Corporation PCL
SET:SUPER
|
TH |
|
P
|
Prime Office A/S
CSE:PRIMOF
|
DK |
|
EverGen Infrastructure Corp
XTSX:EVGN
|
CA |
|
Southern Packaging Group Ltd
SGX:BQP
|
SG |
|
B
|
Bridger Aerospace Group Holdings Inc
NASDAQ:BAER
|
US |
|
R
|
Regional Container Lines PCL
SET:RCL
|
TH |
|
Wentworth Resources PLC
F:1W0
|
JE |
Bankruptcy Probability
Cumberland Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cumberland Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
45.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cumberland Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cumberland Pharmaceuticals Inc has total debt of 5.2m USD. This includes both short-term (0 USD) and long-term (5.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
